Cargando…
Optimum non-invasive predictive indicators for metabolic dysfunction-associated fatty liver disease and its subgroups in the Chinese population: A retrospective case-control study
OBJECTIVE: Metabolic dysfunction-associated fatty liver disease (MAFLD) affects 25% of the population without approved drug therapy. According to the latest consensus, MAFLD is divided into three subgroups based on different diagnostic modalities, including Obesity, Lean, and Type 2 diabetes mellitu...
Autores principales: | Liu, Jing, Duan, Shaojie, Wang, Che, Wang, Yutong, Peng, Hongye, Niu, Zuohu, Yao, Shukun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751395/ https://www.ncbi.nlm.nih.gov/pubmed/36531447 http://dx.doi.org/10.3389/fendo.2022.1035418 |
Ejemplares similares
-
Cardiometabolic index: A new predictor for metabolic associated fatty liver disease in Chinese adults
por: Duan, Shaojie, et al.
Publicado: (2022) -
Nonlinear correlation between fatty liver index and carotid intima media thickness among individuals undergoing health examination
por: Zhou, Yuanchen, et al.
Publicado: (2023) -
Correlation between the Severity of Metabolic Dysfunction-Associated Fatty Liver Disease and Serum Uric Acid to Serum Creatinine Ratio
por: Liu, Jing, et al.
Publicado: (2023) -
Associations Between Abdominal Obesity Indices and Nonalcoholic Fatty Liver Disease: Chinese Visceral Adiposity Index
por: Chen, Xueyu, et al.
Publicado: (2022) -
Novel Subgroups and Chronic Complications of Diabetes in Middle-Aged and Elderly Chinese:A Prospective Cohort Study
por: Wang, Fei, et al.
Publicado: (2022)